Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptiste Bonneau

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|May 15, 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposureFabien Despas, Maria Chaouki, Sandra de Barros, et al.
The British Journal of Dermatology|April 4, 2026
Ophthalmological Abnormalities in syndromic or non-syndromic Epidermal Differentiation Disorders: a cross-sectional studyPierre Fournié, Baptiste Bonneau, Hélène Texier, et al.
Journal of Hypertension|January 21, 2025
Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertensionLoïc Ysebaert, Caroline Protin, Lucie Obéric, et al.
Addiction Science & Clinical Practice|October 15, 2024
Acceptability of "DIDE", a mobile application designed at facilitating care adherence of patients with substance use disorderAntoine Stocker, Nicolas Navarro, Laurent Schmitt, et al.
Annals of Neurology|September 24, 2022
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint InhibitorsXavier Boumaza, Baptiste Bonneau, Damien Roos-Weil, et al.
Transplantation and Cellular Therapy|June 10, 2026
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisAlexandre Chevalier, Baptiste Bonneau, Lea Grote-Levi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|May 15, 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposureFabien Despas, Maria Chaouki, Sandra de Barros, et al.
The British Journal of Dermatology|April 4, 2026
Ophthalmological Abnormalities in syndromic or non-syndromic Epidermal Differentiation Disorders: a cross-sectional studyPierre Fournié, Baptiste Bonneau, Hélène Texier, et al.
Journal of Hypertension|January 21, 2025
Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertensionLoïc Ysebaert, Caroline Protin, Lucie Obéric, et al.
Addiction Science & Clinical Practice|October 15, 2024
Acceptability of "DIDE", a mobile application designed at facilitating care adherence of patients with substance use disorderAntoine Stocker, Nicolas Navarro, Laurent Schmitt, et al.
Annals of Neurology|September 24, 2022
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint InhibitorsXavier Boumaza, Baptiste Bonneau, Damien Roos-Weil, et al.
Transplantation and Cellular Therapy|June 10, 2026
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisAlexandre Chevalier, Baptiste Bonneau, Lea Grote-Levi, et al.
Pageof 1